The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity

Stem Cell Research and Therapy

Volumn 6, Issue 1, 2015, Pages

  Cui, Li Li ^a   Kerkelä, Erja ^b   Bakreen, Abdulhameed ^a   Nitzsche, Franziska ^c   Andrzejewska, Anna ^d   Nowakowski, Adam ^d   Janowski, Miroslaw ^e   Walczak, Piotr ^e   Boltze, Johannes ^c   Lukomska, Barbara ^d   Jolkkonen, Jukka ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b Finnish Red Cross   (Finland)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRON OXIDE;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD BRAIN BARRIER LEAKAGE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BRAIN BLOOD FLOW; BRAIN EMBOLISM; BRAIN HEMORRHAGE; CELL LABELING; CYLINDER TEST; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; EXPERIMENTAL LOCOMOTOR ACTIVITY TEST; EXTERNAL CAROTID ARTERY; HISTOPATHOLOGY; IN VIVO STUDY; INTRAARTERIAL DRUG ADMINISTRATION; LASER DOPPLER FLOWMETRY; LIMB PLACING TEST; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL NECROSIS; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; SENSORIMOTOR FUNCTION; SHAM PROCEDURE; VELOCITY; ALLOTRANSPLANTATION; ANIMAL; ANIMAL BEHAVIOR; BLOOD FLOW VELOCITY; BONE MARROW CELL; BRAIN; CELL CULTURE; CELL SIZE; CYTOLOGY; INTRACRANIAL EMBOLISM; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; WISTAR RAT;

RATTUS; RODENTIA;

ANIMALS; BEHAVIOR, ANIMAL; BLOOD FLOW VELOCITY; BONE MARROW CELLS; BRAIN; CELL SIZE; CELLS, CULTURED; INFUSIONS, INTRA-ARTERIAL; INTRACRANIAL EMBOLISM; LASER-DOPPLER FLOWMETRY; MAGNETIC RESONANCE IMAGING; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; RATS; RATS, WISTAR; TRANSPLANTATION, HOMOLOGOUS;

EID: 84929156481     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt544     Document Type: Article

References (29)

1. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr, American Heart Association Stroke Council: Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 2009, 40:2945-8. 10.1161/STROKEAHA.109.192535
2. Bliss T, Guzman R, Daadi M, Steinberg GK: Cell transplantation therapy for stroke. Stroke. 2007, 38:817-26. 10.1161/01.STR.0000247888.25985.62
3. Lalu MM, Mclntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, et al.: Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One. 2012, 7:e47559. 10.1371/journal.pone.0047559
4. Eckert MA, Vu Q, Xie K, Yu J, Liao W, Cramer SC, et al.: Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke. J Cereb Blood Flow Metab. 2013, 33:1322-34. 10.1038/jcbfm.2013.91
5. Bhasin A, Srivastava MV, Mohanty S, Bhatia R, Kumaran SS, Bose S: Stem cell therapy: a clinical trial of stroke. Clin Neurol Neurosurg. 2013, 115:1003-8. 10.1016/j.clineuro.2012.10.015
6. Lee JS, Hong JM, Moon GJ, Lee PH, Ahn YH, Bang OY, et al.: A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells. 2010, 28:1099-106. 10.1002/stem.430
7. Honmou O, Houkin K, Matsunaga T, Niitsu Y, Ishiai S, Onodera R, et al.: Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain. 2011, 134:1790-807. 10.1093/brain/awr063
8. Goldmacher GV, Nasser R, Lee DY, Yigit S, Rosenwasser R, Iacovitti L: Tracking transplanted bone marrow stem cells and their effects in the rat MCAO stroke model. PLoS One. 2013, 8:e60049. 10.1371/journal.pone.0060049
9. Rosado-de-Castro PH, Schmidt Fda R, Battistella V, de Souza SAL, Gutfilen B, Goldenberg RC, et al.: Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients. Regen Med. 2013, 8:145-55. 10.2217/rme.13.2
10. Lundberg J, Sodersten E, Sundstrom E, Le Blanc K, Andersson T, Hermanson O, et al.: Targeted intra-arterial transplantation of stem cells to the injured CNS is more effective than intravenous administration: engraftment is dependent on cell type and adhesion molecule expression. Cell Transplant. 2012, 21:333-43. 10.3727/096368911X576036
11. Misra V, Ritchie MM, Stone LL, Low WC, Janardhan V: Stem cell therapy in ischemic stroke: role of IV and intra-arterial therapy. Neurology. 2012, 79:S207-12. 10.1212/WNL.0b013e31826959d2
12. Li L, Jiang Q, Ding G, Zhang L, Zhang ZG, Li Q, et al.: Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study. J Cereb Blood Flow Metab. 2010, 30:653-62. 10.1038/jcbfm.2009.238
13. Walczak P, Zhang J, Gilad AA, Kedziorek DA, Ruiz-Cabello J, Young RG, et al.: Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke. 2008, 39:1569-74. 10.1161/STROKEAHA.107.502047
14. Chua JY, Pendharkar AV, Wang N, Choi R, Andres RH, Gaeta X, et al.: Intra-arterial injection of neural stem cells using a microneedle technique does not cause microembolic strokes. J Cereb Blood Flow Metab. 2011, 31:1263-71. 10.1038/jcbfm.2010.213
15. Janowski M, Lyczek A, Engels C, Xu J, Lukomska B, Bulte JW, et al.: Cell size and velocity of injection are major determinants of the safety of intracarotid stem cell transplantation. J Cereb Blood Flow Metab. 2013, 33:921-7. 10.1038/jcbfm.2013.32
16. Jolkkonen J, Puurunen K, Rantakomi S, Harkonen A, Haapalinna A, Sivenius J: Behavioral effects of the alpha(2)-adrenoceptor antagonist, atipamezole, after focal cerebral ischemia in rats. Eur J Pharmacol. 2000, 400:211-9. 10.1016/S0014-2999(00)00409-X
17. Puurunen K, Jolkkonen J, Sirvio J, Haapalinna A, Sivenius J: An alpha (2)-adrenergic antagonist, atipamezole, facilitates behavioral recovery after focal cerebral ischemia in rats. Neuropharmacology. 2001, 40:597-606. 10.1016/S0028-3908(00)00182-9
18. Karhunen H, Virtanen T, Schallert T, Sivenius J, Jolkkonen J: Forelimb use after focal cerebral ischemia in rats treated with an alpha 2-adrenoceptor antagonist. Pharmacol Biochem Behav. 2003, 74:663-9. 10.1016/S0091-3057(02)01053-5
19. Roos MW, Ericsson A, Berg M, Sperber GO, Sjoquist M, Meyerson BJ: Functional evaluation of cerebral microembolization in the rat. Brain Res. 2003, 961:15-21. 10.1016/S0006-8993(02)03829-5
20. Gallyas F, Wolff JR, Bottcher H, Zaborszky L: A reliable and sensitive method to localize terminal degeneration and lysosomes in the central nervous system. Stain Technol. 1980, 55:299-306.
21. Hayward NM, Yanev P, Haapasalo A, Miettinen R, Hiltunen M, Grohn O, et al.: Chronic hyperperfusion and angiogenesis follow subacute hypoperfusion in the thalamus of rats with focal cerebral ischemia. J Cereb Blood Flow Metab. 2011, 31:1119-32. 10.1038/jcbfm.2010.202
22. Jolkkonen J, Jokivarsi K, Laitinen T, Gröhn O: Subacute hemorrhage and resolution of edema in Rose Bengal stroke model in rats coincides with improved sensorimotor functions. Neurosci Lett. 2007, 428:99-102. 10.1016/j.neulet.2007.09.043
23. Ge J, Guo L, Wang S, Zhang Y, Cai T, Zhao RC, et al.: The size of mesenchymal stem cells is a significant cause of vascular obstructions and stroke. Stem Cell Rev. 2014, 10:295-303. 10.1007/s12015-013-9492-x
24. Guo L, Ge J, Zhou Y, Wang S, Zhao RC, Wu Y: Three-dimensional spheroid-cultured mesenchymal stem cells devoid of embolism attenuate brain stroke injury after intra-arterial injection. Stem Cells Dev. 2014, 23:978-89. 10.1089/scd.2013.0338
25. Hickerson DH, White HS, Nguyen A, Nieman E, Meadows N, Gentry T, et al.: Development of a flow cytometry-based pulse-width assay for detection of aggregates in cellular therapeutics to be infused by catheter. Cytotherapy. 2014, 16:1545-57. 10.1016/j.jcyt.2014.05.004
26. Nemeth CL, Shurte MS, McTigue DM, Nemeroff CB, Neigh GN: Microembolism infarcts lead to delayed changes in affective-like behaviors followed by spatial memory impairment. Behav Brain Res. 2012, 234:259-66. 10.1016/j.bbr.2012.06.014
27. Khabbal J, Kerkela E, Mitkari B, Raki M, Nystedt J, Mikkonen V: Differential clearance of rat and human bone marrow-derived mesenchymal stem cells from the brain after intra-arterial infusion in rats. Cell Transplant 2014. DOI: 10.3727/096368914X679336
28. Jiang W, Liang G, Li X, Li Z, Gao X, Feng S, et al.: Intracarotid transplantation of autologous adipose-derived mesenchymal stem cells significantly improves neurological deficits in rats after MCAO. J Mater Sci Mater Med. 2014, 25:1357-66. 10.1007/s10856-014-5157-9
29. Mitkari B, Kerkela E, Nystedt J, Korhonen M, Mikkonen V, Huhtala T, et al.: Intra-arterial infusion of human bone marrow-derived mesenchymal stem cells results in transient localization in the brain after cerebral ischemia in rats. Exp Neurol. 2013, 239:158-62.